Prescription Drug News and Research

RSS

In the first few days of each month, fatalities due to medication errors rise by as much as 25 percent above normal

Beware not the ides but the start of March – and April and May and every month. In the first few days of each month, fatalities due to medication errors rise by as much as 25 percent above normal, according to new research by University of California, San Diego sociologist David Phillips.

6 Jan 2005

The rise in over the counter drugs, why?

Switching of prescription drugs to over the counter availability is increasingly common, but what are the motives behind this trend, ask US researchers in this week's BMJ?

3 Jan 2005

Public health advisory for the use of non-steroidal anti-inflammatory drug products

The Food and Drug Administration (FDA) has issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents.

23 Dec 2004

Pharmacogenomics, has the potential to spark a major, technology-driven restructuring of the health care and pharmaceuticals industries

Pharmacogenomics, the study of genetic variability in the way individuals respond to medicines, has the potential to spark a major, technology-driven restructuring of the health care and pharmaceuticals industries

21 Dec 2004

FDA issues advice on Naproxen

The FDA has released the following statement on NIH halting a clinical trial involving non-steroidal anti-inflammatory drugs in patients at risk of developing Alzheimer's Disease:

20 Dec 2004

Nearly 6 million Americans turned to complementary and alternative medicine because of costs

Nearly 6 million American adults turned to complementary and alternative medicine (CAM) in the past year to treat such conditions as depression and chronic pain because conventional medical treatment was too expensive, according to a national study released today by the Center for Studying Health System Change (HSC).

20 Dec 2004

Advice for patients who have been taking Celebrex or Bextra

The recent announcement that Celebrex, a popular pain drug in the same family as Vioxx, has been found to pose an increased risk of heart problems is bound to leave many pain patients stunned, confused and worried.

20 Dec 2004

Early ritalin may cause long-term effects on the brain

A new study conducted in rats by the National Institutes of Health (NIH) and McLean Hospital/Harvard Medical School suggests that the misdiagnosis of attention-deficit hyperactivity disorder (ADHD) combined with prescription drug use in children may lead to a higher risk of developing depressive symptoms in adulthood.

13 Dec 2004

Prescription drug cost increases continuing to outpace inflation

A new report released today by AARP found the annual rate of manufacturers' price increases for the 197 brand name prescription drugs most commonly used by older Americans more than tripled the rate of inflation over the 12-month period ending on September 30, 2004.

6 Dec 2004

Life expectancy at 65 is now 81.6 years for men and 84.5 for women

The nation’s medicine cabinets are more crowded than ever, with almost half of all people taking at least one prescription medicine and one in six taking three or more medications, according to the U.S. Department of Health and Human Services’ annual check-up on Americans’ health.

4 Dec 2004

U.S. pharmacists not opposed to importing drugs to lower patients' costs

Many community pharmacists are not opposed to importing drugs to lower patients' costs as long as those drugs are channeled through U.S. pharmacies to ensure safety and efficacy, according to a study by pharmacists at the University of Illinois at Chicago and the University of Michigan.

24 Nov 2004

Canadian prescription drugs

Canadian pharmacies that mail prescription drugs to U.S. patients have been backed into a no-win situation by the Canadian government and the provincial medical and pharmacy associations.

16 Nov 2004

FDA commits to use of radio frequency identification (RFID) technology

The U.S. Food and Drug Administration (FDA) is stepping up its efforts to improve the safety and security of the nation's drug supply through the use of radio frequency identification (RFID) technology.

16 Nov 2004

Medicare to reimburse preventive cholesterol screening

As the nation's leading cardiologists gather for the American Heart Association's Scientific Sessions 2004, the Centers for Medicare & Medicaid Service (CMS) has announced the 2005 Physician Fee Schedule, which guarantees access to preventive cholesterol screenings for 39 million Medicare-eligible beneficiaries.

9 Nov 2004

FDA has warned consumers not to purchase or to consume Actra-Rx or Yilishen, promoted as "dietary supplements" for treating erectile dysfunction

The Food and Drug Administration today warned consumers not to purchase or to consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

9 Nov 2004

Obese and overweight men spend 3.5 times more on prescription drugs than normal-weight men

As middle-aged men’s weight goes up, so do their monthly costs for prescription drugs to treat heart disease risk factors and weight-related conditions, according to research presented at the American Heart Association’s Scientific Sessions 2004.

8 Nov 2004

Quitting smoking can be made easier with long-term comprehensive drug and psychological interventions

People who want to quit smoking have an improved chance of success if they receive long-term comprehensive drug and psychological interventions, according to a new study by UCSF researchers.

4 Nov 2004

The Bush Medicare Prescription has changed the identity of medical oncology

Under previous law, Medicare covered chemotherapy as well as radiation treatment for cancer patients, but did not pay for oral-dose anti-cancer drugs, unless they were available in both oral and injectable form.

4 Nov 2004

Generic drugs are still a good buy

A new AARP study found that manufacturers' prices for some generic drugs experienced a rapid rise over the past three years. However, these increases would have added only a few dollars per year to consumers' costs for any one of these products.

4 Nov 2004

FDA warns against use of Actra-Rx and Yilishen

The U.S. Food and Drug Administration has warned consumers not to purchase or to consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

4 Nov 2004